Medical Device News Magazine

Joe Gabler Appointed Chief Growth Office at Paytient

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Paytient, the leading provider of health plan affordability solutions, announces today the addition of Joe Gabler as Chief Growth Officer. Joe Gabler is a senior executive and healthcare consumer payments pioneer with nearly 20 years of experience building companies around winning cultures. Joe will join Paytient to drive growth and expansion as the company continues to partner with leading employers, payers, and PBMs.

Serving over 5,000 enterprise partners with nearly 25 million lives moving into 2025, Paytient welcomes Joe to scale its partnerships with mid-market employers, large commercial groups, leading payers, and Medicare plan sponsors to make healthcare more easily accessible for millions more Americans in the coming years.

“The Medicare Prescription Payment Plan in 2025 means that smoothing out-of-pocket costs over time is becoming a standard of care for healthcare in the United States. Paytient is well positioned to serve as the leading platform giving Americans a better ability to access and afford care,” said Brian Whorley, Founder and CEO of Paytient. “As we prepare for the growth this will bring, Joe’s proven ability to scale teams and operations with winning cultures is a fantastic and critical addition to our leadership team.

Joe Gabler comments:

“Paytient is improving healthcare with a strategy that puts choice and affordability in the hands of members, knowing they need to be at the heart of real change. I’ve seen what can happen when people are empowered to care for their whole health, which is increasingly out of reach these days. I’m incredibly excited to join the amazing team at Paytient and passionately help expand the reach of this mission.”
Joe Gabler spent the first 13 years of his career helping SPS Commerce (SPSC) grow from a small business to a hugely successful IPO and multi-billion dollar market value. There he held multiple operations, strategy, and growth management positions. The next 6 years saw him reinventing the healthcare benefits landscape, leveraging innovative consumer payments strategies at Solutran, now acquired by Optum. They built a market-leading payment network serving over half the Medicare Advantage market and processing billions of dollars yearly in consumer benefit payments. Paytient is excited to welcome Joe onto its executive leadership team and leverage his expertise to pursue new growth opportunities.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”